Cardiff
Cardiff ECMC aims to develop biomarkers, novel therapeutic approaches to cancer treatment and expand tissue banking. The Centre has a particular focus on acute myeloid leukaemia (AML) and conducts pre-clinical testing of novel agents that could lead to new treatments for the disease. Another focus area is translating knowledge of molecular pathways into biomarkers for breast cancer.
Research Areas
Focus
Haematological oncology, pathology, tissue resources
Disease Area
Breast, colon, rectal, leukaemia, prostate, thyroid
Goals
Skills
Cardiff ECMC principal investigators and staff have a diverse range of skills and expertise.
Facilities
Cardiff ECMC has access to a range of research facilities that are utilised in studies.
Achievements
Patient accrual to clinical trials and activity in early phase studies has increased significantly at Cardiff ECMC.
Centre Lead
Centre Lead
Other key personnel
General and Patient Enquiries
Sian Edwards
Room 162, 7th Floor, A-B Block
Department of Haematology
School of Medicine
Cardiff University
Heath Park
Cardiff
CF14 4XN
Tel: +44 (0) 29 2074 2375
Clinical Trial Information
You can also find out about trials recruiting in Cardiff on the CancerHelp UK clinical trials database.
Increase text
Decrease text
Print this page